Hong Kong Reports 10th Case This Year Of Drug-Resistant H1N1 Flu
This article was originally published in PharmAsia News
Hong Kong health authorities have reported the 10th case this year of H1N1 influenza resistant to the two common treatments
You may also be interested in...
GSK commits to investing behind OTC and oral health brands in India after offloading nutrition assets to Unilever.
The Belgian biotech has managed to attract considerable sums from venture capitalists over the past couple of years amid hopes that its two next-generation immunotherapies will be best-in-class agents.
Cipla is celebrating an “important milestone” for the company after the successful completion of a Phase III clinical trial comparing its proposed Advair generic with GSK’s brand in the US. Management has cautioned that approval will be a way off yet, however.